
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Quebec City in 1994, Montreal in 2001 and Toronto in 2007!
TORONTO, CANADA, July 26, 2007-Over the past fourteen years Anapharm has established itself as a world class provider of clinical and bioanalytical services to international sponsors and offers strategically located operations in five Canadian cities. Most recently, we opened a 160-bed clinical facility in Toronto, Canada.
Toronto site features:






